P

Passage Bio
D

PASG

16.345
USD
-1.75
(-9.65%)
مفتوح الان
حجم التداول
732
الربح لكل سهم
-11
العائد الربحي
-
P/E
-1
حجم السوق
51,956,015
المقالات

العنوان: Passage Bio Inc

القطاع: Healthcare
الصناعة: Biotechnology
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.